1. 2018
  2. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications

    Kuiper, G-A., Meijer, O. L. M., Langereis, E. J. & Wijburg, F. A., 2018, In: Orphanet journal of rare diseases. 13, 1, p. 2

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Unfolding mucopolysaccharidosis type III: Pathophysiology, diagnosis and treatment

    Meijer, O. L. M., 2018

    Research output: ThesisPhd-Thesis - Research and graduation internal

  4. 2017
  5. High-Throughput Screen Fails to Identify Compounds That Enhance Residual Enzyme Activity of Mutant N-Acetyl-α-Glucosaminidase in Mucopolysaccharidosis Type IIIB

    Meijer, O. L. M., van den Biggelaar, P., Ofman, R., Wijburg, F. A. & van Vlies, N., 2017, In: JIMD reports. 39, p. 97-106

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Processing of mutant N-acetyl-alpha-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature

    Meijer, O. L. M., te Brinke, H., Ofman, R., IJlst, L., Wijburg, F. A. & van Vlies, N., 2017, In: Molecular genetics and metabolism. 122, 1-2, p. 100-106

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2016
  8. Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB

    Meijer, O. L. M., Welling, L., Valstar, M. J., Hoefsloot, L. H., Brüggenwirth, H. T., van der Ploeg, A. T., Ruijter, G. J. G., Wagemans, T., Wijburg, F. A. & van Vlies, N., 2016, In: Journal of inherited metabolic disease. 39, 3, p. 437-445

    Research output: Contribution to journalArticleAcademicpeer-review

  9. 2013
  10. Treatment of mucopolysaccharidosis type III (Sanfilippo syndrome)

    Meijer, O. L. M., van Vlies, N. & Wijburg, F. A., 2013, In: Expert opinion on orphan drugs. 1, 9, p. 717-730

    Research output: Contribution to journalReview articleAcademicpeer-review

  11. 2011
  12. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation

    van Vuurden, D. G., Hulleman, E., Meijer, O. L. M., Wedekind, L. E., Kool, M., Witt, H., Vandertop, P. W., Würdinger, T., Noske, D. P., Kaspers, G. J. L. & Cloos, J., 2011, In: Oncotarget. 2, 12, p. 984-996

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 111370